Pharmacological strategies and micrometastasis: what is known? What must be done?

Area of Science:

• Oncology
• Cancer Metastasis Research

Background:

• Metastasis is responsible for over 90% of cancer deaths, yet current therapies primarily target primary tumors.
• There is a critical need for novel drugs that specifically inhibit metastatic processes and treat minimal residual disease with reduced toxicity.

Purpose of the Study:

• To investigate the conditions under which specific antimetastatic drugs can be discovered.
• To identify existing drugs with potential antimetastatic activity that do not impact primary tumor growth.

Main Methods:

• Analysis of mechanisms of action for current experimental and clinical antimetastatic drugs.
• Evaluation of the utility of these drugs in various clinical settings, including primary prevention and adjuvant therapy.

Main Results:

• Current therapeutic strategies largely overlook metastasis, focusing instead on primary tumor eradication.
• The study explores the potential for developing drugs that specifically target cancer cell colonization and outgrowth at distant sites.

Conclusions:

• Evidence suggests that specific antimetastatic drugs can be developed.
• Future research and clinical development hold promise for new treatments targeting cancer metastasis.